A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies

References

• Schröder F.H., Hugosson J., Roobol M.J., Tammela T.L.J., Zappa M., Nelen V., et al. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet, 2014;384:2027–2035.
   PubMed Web of Science ®Google Scholar
• Stattin P., Carlsson S., Holmström B., Vickers A., Hugosson J., Lilja H., et al. Prostate cancer mortality in areas with high and low prostate cancer incidence. JNCI Journal of the National Cancer Institute, 2014;106:dju007.
   PubMedGoogle Scholar
• Arnsrud Godtman R., Holmberg E., Lilja H., Stranne J., Hugosson J. Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial Eur Urol, 2014;68:354–360.
   PubMed Web of Science ®Google Scholar
• Nordström T., Aly M., Clements M.S., Weibull C.E., Adolfsson J., Grönberg H. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: Results from a population-based study, 2003–2011. Eur Urol, 2013;63:419–425.
   PubMed Web of Science ®Google Scholar
• Bratt O., Lundgren R., Ahlgren G. Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project. Läkartidningen, 2012;109:1610–1612.
   PubMedGoogle Scholar
• Liu L., Cozen W., Bernstein L., Ross R.K., Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst, 2001;93:705–709.
   PubMedGoogle Scholar
• Morgan R.M., Steele RJC, Nabi G., McCowan C. Socioeconomic variation and prostate specific antigen testing in the community: A United Kingdom based population study. J Urol, 2013;190:1207–1212.
   PubMed Web of Science ®Google Scholar
• Gorday W., Sadrzadeh H., de Koning L., Naugler C. Association of sociodemographic factors and prostate-specific antigen (PSA) testing. Clin Biochem, 2014;47:164–169.
   PubMed Web of Science ®Google Scholar
• Berglund A., Garmo H., Robinson D., Tishelman C., Holmberg L., Bratt O., et al. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer. Eur J Cancer, 2012;48:75–84.
   PubMed Web of Science ®Google Scholar
• Rapiti E., Fioretta G., Schaffar R., Neyroud-Caspar I., Verkooijen H.M., Schmidlin F., et al. Impact of socioeconomic status on prostate cancer diagnosis, treatment, and prognosis. Cancer, 2009;115:5556–5565.
   PubMed Web of Science ®Google Scholar
• Barlow L., Westergren K., Holmberg L., Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol, 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Drazer M.W., Huo D., Schonberg M.A., Razmaria A., Eggener SE. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. J Clin Oncol, 2011;29:1736–1743.
   PubMed Web of Science ®Google Scholar
• Eisen S.A., Waterman B., Skinner C.S., Scherrer J.F., Romeis J.C., Bucholz K., et al. Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology, 1999;53:516–522.
   PubMed Web of Science ®Google Scholar
• Finney Rutten L.J., Meissner H.I., Breen N., Vernon S.W., Rimer B.K. Factors associated with men's use of prostate-specific antigen screening: Evidence from Health Information National Trends Survey. Prev Med, 2005;40:461–468.
   PubMed Web of Science ®Google Scholar
• Karlsen R.V., Larsen S.B., Christensen J., Brasso K., Friis S., Tjønneland A., et al. PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study. Acta Oncol, 2013;52:1609–1614.
   PubMed Web of Science ®Google Scholar
• William N., Hughes L.J., Turner E.L., Donovan J.L., Hamdy F.C., Neal D.E., et al. Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities. BJU Int, 2011;108:1402–1408.
   PubMed Web of Science ®Google Scholar
• Drazer M.W., Huo D., Eggener SE. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. J Clin Oncol, 2015;33:2416–2423
   PubMed Web of Science ®Google Scholar
• Abdoli G., Bottai M., Moradi T. Cancer mortality by country of birth, sex, and socioeconomic position in Sweden, 1961–2009. PLoS One, 2014;9:e93174.
   PubMed Web of Science ®Google Scholar
• Broberg G., Gyrd-Hansen D., Miao Jonasson J., Ryd M-L, Holtenman M., Milsom I., et al. Increasing participation in cervical cancer screening: Offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer, 2014;134:2223–2230.
   PubMed Web of Science ®Google Scholar
• Andriole G.L., Crawford E.D., Grubb R.L., Buys S.S., Chia D., Church T.R., et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up. JNCI Journal of the National Cancer Institute, 2012;104:125–132.
   PubMed Web of Science ®Google Scholar
• Kalager M., Zelen M., Langmark F., Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med, 2010;363:1203–1210.
   PubMed Web of Science ®Google Scholar
• Mackenbach J.P., Stirbu I., Roskam A-JR, Schaap M.M., Menville G., Leinsalu M., et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med, 2008;358:2468–2481.
   PubMed Web of Science ®Google Scholar
• Shavers V.L. Measurement of socioeconomic status in health disparities research. J Natl Med Assoc, 2007;99:1013–1023.
   PubMed Web of Science ®Google Scholar